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Abstract
Background: While early pneumonia is common in patients after out-of-hospital cardiac arrest (OHCA), little is
known about the impact of pneumonia and the optimal timing of antibiotic therapy after OHCA.
Methods: We conducted a 5-year retrospective cohort study, including patients who suffered from OHCA and were
treated with therapeutic hypothermia. ICU treatment was strictly standardized with defined treatment goals and
procedures. Medical records, chest radiographic images and microbiological findings were reviewed.
Results: Within the study period, 442 patients were admitted to our medical ICU after successfully resuscitated
cardiac arrest. Of those, 174 patients fulfilled all inclusion and no exclusion criteria and were included into final
analysis. Pneumonia within the first week could be confirmed in 39 patients (22.4 %) and was confirmed or probable
in 100 patients (57.5 %), without a difference between survivors and non-survivors (37.8 % vs. 23.1 % confirmed
pneumonia, p = 0.125). In patients with confirmed pneumonia a tracheotomy was performed more frequently (28.2
vs. 12.6 %, p = 0.026) compared to patients without confirmed pneumonia. Importantly, patients with confirmed
pneumonia had a longer ICU- (14.0 [8.5-20.0] vs. 8.0 [5.0-14.0] days, p < 0.001) and hospital stay (23.0 [11.5-29.0] vs.
15.0 [6.5-25.0] days, p = 0.016).
A positive end expiratory pressure (PEEP) > =10.5 mbar on day 1 of the hospital stay was identified as early
predictor of confirmed pneumonia (odds ratio 2.898, p = 0.006). No other reliable predictor could be identified.
Median time to antibiotic therapy was 8.7 [5.4-22.8] hours, without a difference between patients with or without
confirmed pneumonia (p = 0.381) and without a difference between survivors and non-survivors (p = 0.264). Patients
receiving antibiotics within 12 hours after admission had a shorter ICU- (8.0 [4.0-14.0] vs. 10.5 [6.0-16.0] vs. 13.5
[8.0-20.0] days, p = 0.004) and hospital-stay (14.0 [6.0-25.0] vs. 16.5 [11.0-27.0] vs. 21.0 [17.0-28.0] days, p = 0.007)
compared to patients receiving antibiotics after 12 to 36 or more than 36 hours, respectively.
Conclusions: Early pneumonia may extend length of ICU- and hospital-stay after OHCA and its occurrence is
difficult to predict. A delayed initiation of antibiotic therapy in OHCA patients may increase the duration of the ICU-
and hospital-stay.
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Background
The annual incidence of out-of-hospital cardiac arrest
(OHCA) is around 35 per 100,000, of which only about
10 % survive until hospital discharge [1–3]. The high
mortality rate of patients who initially achieve return of
spontaneous circulation (ROSC) can be attributed to a
pathophysiological process which is called postcardiac
arrest syndrome [4]. As part of the postcardiac arrest
syndrome, ischemia/reperfusion activates immunological
pathways contributing to an increased risk of infection
[5–7]. Indeed, infectious complications occur frequently
after OHCA, especially in the early phase [8, 9]. How-
ever, because of confounding factors, appropriate and
prompt diagnosis of infection after OHCA remains
challenging.
For instance, therapeutic hypothermia, which is rec-
ommended in survivors of OHCA to improve their
neurological outcome [2, 4], complicates the diagnosis of
infection because changes in body temperature cannot
be considered. Moreover, whether or not hypothermia it-
self may impair the immune system and increase infec-
tion rates is still a matter of debate [9–11]. Remarkably,
while infections are common and difficult to diagnose
after OHCA, little is known about the impact of timing
of antibiotic therapy in those patients.
We hypothesized that, after OHCA, early pneumonia
is common, has prognostic impact, and can be predicted
by clinical variables. Thus, we conducted a retrospective
cohort study aiming to analyze the incidence and the
impact of early pneumonia, to identify possible early
predictors of pneumonia, and to analyze the impact of
timing of antibiotic therapy on the occurrence of pneu-
monia and outcome after OHCA.
Methods
Study design and study population
We performed a 5-year retrospective cohort study includ-
ing patients admitted to our medical ICU in a university
hospital between 1 January 2010 and 31 December 2014
after successful resuscitation for OHCA. The study was
approved by the local ethics committee of the university
hospital of Göttingen, Germany.
Definitions and standard care on our ICU
All original chest radiographies performed within the
first 7 days of hospitalization were analyzed by a single
experienced radiologist (MF) for new or progressive in-
filtrates. This radiologist was blinded to all clinical data
(e.g., microbiological findings) and only interpreted the
original chest X-ray images in batches. Chest radiogra-
phies were classified into one of four categories—new or
progressive infiltrates were: (category 1) definitely present,
(category 2) probably present, (category 3) unlikely, or
(category 4) excluded. According to published criteria of
the International Sepsis Forum Consensus Conference
[12] we distinguished between confirmed pneumonia and
probable pneumonia. Confirmed pneumonia was diag-
nosed when new radiographic infiltrates on chest radiog-
raphy were present (category 1) in combination with
clinical suspicion and the isolation of a pulmonary patho-
gen from a lower respiratory tract sample. Bacteriological
findings considered to cause pneumonia are summarized
in Additional file 1. For microbiological confirmation,
semiquantitative Gram staining was performed on each
specimen. Semiquantitative cultures were processed ac-
cording to standard culture procedures. The microbio-
logical investigation was defined positive if in the Gram
staining two or more (oil immersion (×1000) per field)
bacteria were found and the culture was positive. We ex-
cluded Staphylococcus epidermidis, Enterococcus species,
and Streptococcus agalactiae to be a causative agent for
pneumonia. Clinical suspicion was assumed when at least
one of the following criteria was present: purulent spu-
tum; auscultation findings suspicious for pneumonia; or
hypoxemia (Partial pressure of oxygen in arterial
blood (PaO2) /Fraction of inspired oxygen (FiO2) <240).
Probable pneumonia was diagnosed without a microbio-
logical confirmation in the presence of a new or progres-
sive infiltrate on chest radiography (category 1) when
pneumonia was clinically present (defined as purulent
sputum plus at least one of the criteria of suspicious aus-
cultation findings or hypoxemia). We also diagnosed a
probable pneumonia when pneumonia was clinically
present (see earlier), a suspicious pulmonary pathogen
from a lower respiratory tract sample could be isolated
(see earlier), and chest radiography revealed a probable in-
filtrate (category 2). Early pneumonia was defined as con-
firmed pneumonia or probable pneumonia within 7 days.
Treatment of OHCA patients admitted to our ICU is
strictly standardized. Treatment goals and procedures
and further definitions are provided in Additional file 2.
Data analysis and statistical methods
Data were collected and analyzed using Microsoft Excel,
SPSS version 22.0 (SPSS, Inc., Chicago, IL, USA) and R
version 3.1.2 (The R Foundation for Statistical Comput-
ing, Vienna, Austria). Proportions are expressed as per-
centages and as absolute numbers. Continuous variables
are given as the median value (25th–75th percentiles).
Statistical tests used in this study were two-tailed and
used a significance level of 0.05. Categorical variables
were compared using the Fisher’s exact test. Compari-
sons of continuous variables were performed with the
Mann–Whitney U test. To test for correlations between
continuous variables, the Spearman correlation coeffi-
cient (r) was calculated. To identify possible predictors
of pneumonia we dichotomized numerous variables (in-
cluding patient demographic characteristics, cardiovascular
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risk factors, parameters of resuscitation, laboratory values
indicating infection, hemodynamic and respiratory param-
eters) according to the occurrence of pneumonia. Since
we wanted to identify early markers of pneumonia, only
parameters available within the first 3 days after admission
were analyzed. Variables included in our definition of
pneumonia diagnosis (e.g., purulent sputum) were not
considered. Since all patients were treated with thera-
peutic hypothermia, fever was also not considered. How-
ever, since the median time until rewarming was 46.8
(43.0–50.1) hours, we included the occurrence of post-
hypothermia fever (for definition see Additional file 2) in
the analysis. Receiver operating characteristic (ROC) ana-
lysis was performed for baseline parameters significantly
different between patients with and without pneumonia,
and the area under the curve (AUC) was calculated
with regard to the occurrence of confirmed pneumo-
nia. Youden Index quantification was used to identify
the optimal cutoff value for the prediction of pneu-
monia. For the optimal cutoff value, the specificity,
sensitivity, and negative and positive predictive values
were calculated and univariate logistic regression ana-
lysis was performed to obtain the odds ratio (OR)
with the corresponding 95 % confidence intervals
(95 % CIs). In-hospital death was analyzed as the pri-
mary outcome parameter. Secondary outcome param-
eters were time to extubation (days), length of ICU
stay (days), length of hospital stay (days), and need
for tracheotomy. Time to extubation was analyzed for
all patients extubated within their ICU stay, when no
reintubation or tracheotomy was necessary.
Results
Patient population
Between January 2010 and January 2015, 442 patients
were admitted to our medical ICU after primarily surviv-
ing cardiac arrest. Of those, 174 patients were included
into the final study analysis. Figure 1 shows a flow chart of
patient enrollment and exclusion. Patient characteristics, diag-
nostics, and therapeutic procedures are summarized in Table 1
(dichotomized according to survivors and nonsurvivors).
In nonsurvivors, the median time to death was 5.5
(3.5–9.5) days.
Incidence and impact of early pneumonia
Overall, 591 chest X-ray scans were performed within the
first 7 days (mean 0.49 X-ray images per patient per day)
and evaluated with regard to the presence of infiltrates. In
92 images (15.6 %) infiltrates could be excluded, in 136 im-
ages (23.0 %) infiltrates were rated unlikely, and in 205 im-
ages (34.7 %) infiltrates were rated probably present. In 158
X-ray images (26.7 %) infiltrates were definitely confirmed.
Early pneumonia within 7 days could be confirmed in
39 patients (22.4 %). One hundred patients (57.5 %) had
either a confirmed or a probable early pneumonia within
7 days. Of note, 32 patients (18.4 %) had a confirmed
pneumonia and 93 patients (53.4 %) had either a con-
firmed or probable pneumonia within 5 days.
In all patients diagnosed to have a confirmed pneumo-
nia within 7 days, we evaluated which of the three re-
quired criteria (clinical suspicion, presence of infiltrates
on chest X-ray scan, and bacteriological finding consid-
ered to cause pneumonia; see Methods) was the last to
become positive. The last criterion becoming positive
was a bacteriological finding in 31 of 39 patients
(79.5 %), an infiltrate on chest X-ray scan in 4 of 39 pa-
tients (10.3 %), and clinical suspicion in 0 of 39 patients
(0 %). In four patients (10.3 %) an infiltrate on chest
X-ray scan and a bacteriological finding considered to
cause pneumonia were found on the same day. Of note, in
none of the four patients in which a positive chest X-ray
image was the last criterion becoming positive was a chest
X-ray scan performed the day before. This may indicate a
potential delay in diagnosis for those patients, caused by
the fact that chest radiography was not performed daily in
our ICU. There was no difference regarding the incidence
Fig. 1 Flow chart of patient enrollment and exclusion
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of confirmed pneumonia between survivors and nonsurvi-
vors (37.8 % vs. 23.1 %, p = 0.125). Similarly, confirmed or
probable pneumonia was found as often in survivors as in
nonsurvivors (60.5 % vs. 51.7 %, p = 0.333). Patients with
confirmed pneumonia had a longer ICU stay (14.0 (8.5–
20.0) vs. 8.0 (5.0–14.0) days, p <0.001) and hospital stay
(23.0 (11.5–29.0) vs. 15.0 (6.5–25.0) days, p = 0.016) com-
pared with patients without pneumonia, while there was
no difference regarding the time to extubation (6.5 (3.6–
9.4) vs. 4.5 (3.5–8.4) days, p = 0.204) (Fig. 2). The rate of
tracheotomy was higher in patients with confirmed pneu-
monia compared with patients without pneumonia (28.2
vs. 12.6 %, p = 0.026).
Likewise, in patients with confirmed or probable pneu-
monia, the time to extubation (5.6 (4.2–9.5) vs. 4.1 (2.9–
6.5) days, p = 0.033) and the length of ICU stay (11.0
(7.0–16.5) vs. 8.0 (4.0–13.0) days, p = 0.002) were in-
creased. The length of hospital stay (17.0 (10.0–27.0) vs.
13.5 (5.0–25.0), p = 0.064) and the rate of tracheotomy
(18.0 vs. 13.5 %, p = 0.533) did not differ between patients
with or without confirmed or probable pneumonia.
Predictors of pneumonia
Numerous variables available within 3 days after hospital
admission (Table 2 and Additional file 3) were dichoto-
mized according to pneumonia diagnosis. Patients with
Table 1 Baseline characteristics, cardiovascular risk factors, parameters of resuscitation, diagnostic work-up, diagnosis, and therapy
for all patients and dichotomized according to survivors and nonsurvivors
Variable All patients (n = 174) Survivors (n = 114) Nonsurvivors (n = 60) p value
Age (years) 69.0 (57.0–77.0) 64.5 (53.0–73.0) 74.0 (64.5–80.0) <0.001
Sex category =male 135 (77.6 %) 92 (80.7 %) 43 (71.7 %) 0.185
Cardiovascular risk factors
Hypertension 96 (55.2 %) 63 (55.3 %) 33 (55.0 %) 1.000
Diabetes mellitus 39 (22.4 %) 23 (20.2 %) 16 (26.7 %) 0.344
Adipositas 28 (16.1 %) 18 (15.8 %) 10 (16.7 %) 1.000
Known CVD 40 (23.0 %) 20 (17.5 %) 20 (33.3 %) 0.023
Cardiopulmonary resuscitation
Free interval (minutes), n = 146 5.0 (0.0–10.0) 2.0 (0.0–10.0) 7.5 (2.0–10.0) 0.006
First rhythm
VT 3 (1.7 %) 3 (2.6 %) 0 (0.0 %) 0.552
VF 113 (64.9 %) 89 (78.1 %) 24 (40.0 %) <0.001
Asystole 34 (19.5 %) 9 (7.9 %) 25 (41.7 %) <0.001
PEA 17 (9.8 %) 8 (7.0 %) 9 (15.0 %) 0.110
Other or unknown 7 (4.0 %) 5 (4.4 %) 2 (3.3 %) 1.000
Time to ROSC (minutes), n = 146 24.5 (15.0–35.0) 20.0 (14.0–31.0) 30.0 (17.8–35.0) 0.023
Witnessed aspiration 22 (12.6 %) 15 (13.2 %) 7 (11.7 %) 1.000
Diagnostic workup
Coronary angiography 149 (85.6 %) 106 (93.0 %) 43 (71.7 %) <0.001
Diagnosis/suspected cause of cardiac arrest
STEMI 57 (32.8 %) 47 (41.2 %) 10 (16.7 %) 0.001
NSTEMI 34 (19.5 %) 23 (20.2 %) 11 (18.3 %) 0.843
Pulmonary embolism 5 (2.9 %) 3 (2.6 %) 2 (3.3 %) 1.000
Primary arrhythmia 26 (14.9 %) 14 (12.3 %) 12 (20.0 %) 0.186
Other or unknown 52 (29.9 %) 27 (23.7 %) 25 (41.7 %) 0.016
Therapy
Impella or IABP 38 (21.8 %) 29 (25.4 %) 9 (15.0 %) 0.126
PCI 80 (46.0 %) 61 (53.5 %) 19 (31.7 %) 0.007
For definitions, see Methods. Data presented as absolute numbers (percentages) or medians (25th–75th percentile). n refers to the number of patients with
available data. p values were calculated by the Mann–Whitney U test or Fisher’s exact test
CVD coronary vascular disease, IABP intraaortic balloon pump, NSTEMI non-ST-elevation myocardial infarction, PEA pulseless electrical activity, PCI percutaneous
coronary intervention, ROSC return of spontaneous circulation, STEMI ST-elevation myocardial infarction, VF ventricular fibrillation, VT ventricular tachycardia
For variables that are statistically different betwen survivors and non-survivors given p-values are highlighted by bold characters
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confirmed pneumonia and patients with confirmed or
probable pneumonia had higher levels of the maximum
positive end-expiratory pressure (PEEP) on day 1 com-
pared with patients without pneumonia. Maximal PEEP
correlated negatively with the minimal PO2/FiO2 value
of the same day (day 1, r = −0.614; day 2, r = −0.629; day
3, r = −0.650; p <0.001 for all). ROC analysis for the
PEEP level on day 1 with regard to the occurrence of
confirmed pneumonia and sensitivity and specificity ana-
lysis are presented in Additional file 4. Overall, 73.0 % of
patients had a maximum PEEP value on day 1 below
10.5 mbar which was identified as optimal cutoff. Max-
imum PEEP values ≥10.5 mbar on day 1 were associated
with an increased risk for the occurrence of confirmed
pneumonia in univariate logistic regression analysis (OR
2.621 (95 % CI 1.370–5.014), p = 0.004).
Timing of antibiotic therapy
All patients included in this study received antibiotic
therapy (Fig. 1). In 166 patients (95.4 %), piperacillin
tazobactam was given as initial antibiotic therapy, either
alone (68.1 %) or in combination with clarithromycin
(31.9 %). Five patients (2.9 %) received amoxicillin clavula-
nic acid or ampicillin sulbactam combined with clarithro-
mycin as initial antibiotic therapy. Meropenem was given
to two patients (1.2 %), and one patient (0.6 %) was treated
with ceftriaxone in combination with erythromycin.
The median time until an antibiotic therapy was initi-
ated was 8.7 hours (5.4–22.8 hours) without a difference
between patients with or without confirmed pneumonia
(8.9 (5.4–29.0) vs. 8.6 (5.5–21.9) hours, p = 0.497) and
patients with or without confirmed or probable pneumo-
nia (7.7 (5.1–24.2) vs. 11.3 (6.6–22.5) hours, p = 0.263).
Likewise, there was no difference between survivors and
nonsurvivors (10.4 (5.4–26.1) vs. 8.0 (5.8–16.0) hours,
p = 0.264). However, patients needing a tracheotomy in
the clinical course (28 patients, 16.1 %) had a later initi-
ation of antibiotic therapy (22.5 (6.5–36.9) vs. 8.1 (5.4–
20.0) hours, p = 0.029). Furthermore, we found a weak but
significant correlation between the time until an antibiotic
Fig. 2 Impact of early pneumonia on time to extubation, length of ICU stay, and length of hospital stay. a Comparison between patients with or
without confirmed or probable pneumonia. b Comparison between patients with or without confirmed pneumonia
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Table 2 Comparison of patients with and without confirmed pneumonia – all parameters available within 3 days
All patients No confirmed pneumonia Confirmed pneumonia p value
(n = 174) (n = 135) (n = 39)
Age (years) 69.0 (57.0–77.0) 68.0 (57.0–76.5) 72.0 (60.0–77.5) 0.303
Sex category =male 135 (77.6 %) 104 of 135 (77.0 %) 31 of 39 (79.5 %) 0.830
Cardiovascular risk factors
Smoking 65 (37.4 %) 51 of 135 (37.8 %) 14 of 39 (35.9 %) 0.493
Hypertension 96 (55.2 %) 72 of 135 (53.3 %) 24 of 39 (61.5 %) 0.465
Diabetes mellitus 39 (22.4 %) 33 of 135 (24.4 %) 6 of 39 (15.4 %) 0.281
Adipositas 28 (16.1 %) 23 of 135 (17.0 %) 5 of 39 (12.8 %) 0.627
Known coronary vascular disease 40 (23.0 %) 29 of 135 (21.5 %) 11 of 39 (28.2 %) 0.393
Cardiopulmonary resuscitation
Free interval (minutes) 5.0 (0.0–10.0) 5.0 (0–10.0) 3.0 (0–10.0) 0.928
First rhythm
Ventricular tachycardia 3 (1.7 %) 3 of 135 (2.2 %) 0 of 39 (0.0 %) 1.000
Ventricular fibrillation 113 (64.9 %) 88 of 135 (65.2 %) 25 of 39 (64.1 %) 1.000
Asystole 34 (19.5 %) 27 of 135 (20.0 %) 7 of 39 (17.9 %) 1.000
Pulseless electrical activity 17 (9.8 %) 12 of 135 (8.9 %) 5 of 39 (12.8 %) 0.540
Other or unknown 7 (4.0 %) 5 of 135 (3.7 %) 2 of 39 (5.1 %) 0.654
Time to ROSC (minutes) 24.5 (15.0–35.0) 25.0 (15.0–35.0) 22.0 (15.5–34.8) 0.666
Witnessed aspiration 22 (12.6 %) 18 of 135 (13.3 %) 4 of 39 (10.3 %) 0.787
Laboratory values
CRP (mg/l) on admission (day 1), n = 170 3.0 (2.0–10.4) 3.0 (2.0–8.9) 2.9 (2.0–20.9) 0.915
CRP (mg/l) on day 2, n = 173 24.0 (8.6–50.7) 23.1 (8.7–48.1) 25.3 (7.0–52.7) 0.943
CRP (mg/l) on day 3, n = 169 124.1 (89.6–166.0) 124.2 (93.5–159.2) 123.6 (81.6–197.5) 0.896
WBC (103/μl) on admission (day 1), n = 174 15.5 (10.7–19.1) 15.2 (10.6–18.2) 16.6 (11.2–21.0) 0.237
WBC (103/μl) day 2, n = 174 12.7 (9.2–17.5) 12.9 (9.6–17.4) 10.3 (9.1–17.1) 0.295
WBC (103/μl) day 3, n = 170 12.3 (9.1–15.6) 12.5 (9.3–15.9) 11.2 (8.4–14.9) 0.204
PCT (μg/l) day 1, n = 121a 0.1 (0.1–0.6) 0.1 (0.1–0.5) 0.2 (0.1–1.1) 0.312
PCT (μg/l) day 2, n = 83a 1.9 (0.5–7.7) 2.0 (0.5–10.2) 1.2 (0.5–2.7) 0.271
PCT (μg/l) day 3, n = 89a 1.7 (0.5–6–1) 1.6 (0.6–6.1) 3.0 (0.5–6.0) 0.642
Lactate (mmol/l) on admission, n = 172 3.7 (2.2–6.8) 5.4 (3.3–7.9) 4.7 (3.2–6.6) 0.301
Respiration
PO2/FiO2 minimum on day 1 152 (100–228) 152 (100–230) 161 (109–211) 0.891
PO2/FiO2 minimum on day 2 165 (121–222) 160 (117–220) 167 (132–220) 0.502
PO2/FiO2 minimum on day 3 160 (126–205) 160 (127–206) 155 (128–188) 0.479
PEEP maximum (mbar) on day 1 8.5 (7.0–11.0) 8.0 (7.0–10.0) 10.0 (8.0–12.0) 0.014
PEEP maximum (mbar) on day 2 9.0 (7.0–11.0) 8.0 (7.0–10.0) 10.0 (7.5–12.0) 0.114
PEEP maximum (mbar) on day 3 9.0 (7.0–12.0) 8.0 (7.0–12.0) 9.0 (7.0–11.5) 0.603
Hemodynamics
Vasopressor dosageb (μg/minute) on day 1 16.0 (8.0–32.0) 16.0 (8.0–30.0) 14.0 (9.5–33.5) 0.712
Vasopressor dosageb (μg/minute) on day 2 19.0 (10.0–32.0) 20.0 (10.0–32.0) 18.0 (10.0–33.0) 0.983
Vasopressor dosageb (μg/minute) on day 3 16.0 (9.0–32.0) 16.0 (9.0–32.0) 16.0 (9.5–38.0) 0.941
Volume infusion (l) on day 1 4.7 (3.1–7.0) 4.5 (3.0–6.9) 5.1 (3.2–7.6) 0.469
Volume infusion (l) on day 2 7.0 (5.0–9.8) 7.3 (5.3–9.8) 6.8 (4.3–9.3) 0.396
Volume infusion (l) on day 3 4.5 (3.4–6.4) 4.4 (3.4–6.4) 4.8 (3.9–6.1) 0.347
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therapy was started and the duration of the ICU stay (cor-
relation coefficient r = 0.17, p = 0.026) and the hospital
stay (correlation coefficient r = 0.17, p = 0.026). For further
analysis, we grouped all patients into one of three classes
according to timing of antibiotic therapy: antibiotics were
given within 12 hours (category I, 101 patients, 58.0 %),
12–36 hours (category II, 51 patients, 29.3 %) or after
more than 36 hours (category III, 22 patients, 12.6 %), re-
spectively. When grouped into categories, length of ICU
stay (8.0 (4.0–14.0) vs. 10.5 (6.0–16.0) vs. 13.5 (8.0–20.0)
days for category I, II, and III, respectively; p = 0.004) and
length of hospital stay (14.0 (6.0–25.0) vs. 16.5 (11.0–27.0)
vs. 21.0 (17.0–28.0) days for category I, II, and III, respect-
ively; p = 0.007) was shorter in patients receiving early an-
tibiotics (Fig. 3).
Discussion
Our study has three main findings: 1) early pneumonia
occurs frequently in patients treated with therapeutic
hypothermia after OHCA, but is difficult to predict; 2)
early pneumonia after OHCA may increase the rate of
tracheotomy and extend the length of the ICU and hos-
pital stay; and 3) a delayed initiation of antibiotic therapy
after OHCA may increase the length of the ICU and hos-
pital stay.
Incidence of early pneumonia
We found an incidence of 22.4 % for confirmed pneu-
monia and 57.5 % for confirmed or probable pneumonia
within 7 days after hospital admission. In the literature,
early pneumonia is reported to occur in 27.5–65 % of
patients treated with therapeutic hypothermia after
OHCA [8, 9, 13–18]. The large heterogeneity across dif-
ferent studies might be caused by differences regarding
the definition of early pneumonia. Moreover, diagnosis
of pneumonia is challenging, since common criteria such
as body temperature and leukocytosis may be affected
by hypothermia and can therefore not be employed. An-
other challenging fact regarding the definition of pneumo-
nia is that interobserver agreement in the interpretation of
chest radiographs for pneumonia is reported to be moder-
ate [19], indicating that confirmation of infiltrates may not
Table 2 Comparison of patients with and without confirmed pneumonia – all parameters available within 3 days (Continued)
Infection and antibiotics
Time to antibiotics (hours) 8.7 (5.4–22.8) 8.5 (5.4–22.4) 9.0 (6.0–26.9) 0.381
Post-hypothermia fever, n = 135c 75 of 135 (55.6 %) 54 of 101 (53.5 %) 21 of 34 (61.8 %) 0.431
Data presented as absolute numbers (percentages) or median (25th–75th percentile). n refers to the number of patients with available data
We also tested whether or not there was a difference of any of the presented parameters between patients with or without confirmed or probable pneumonia.
Data are presented in Additional file 3
aMissing data, because PCT values are not measured routinely every day in our ICU
bIntravenous vasopressors were given in order to maintain a mean arterial pressure (MAD) of >65 mmHg. Norepinephrine was used as vasopressor of first choice;
epinephrine was used when a second vasopressor was necessary to maintain MAD. When a second vasopressor was necessary, numbers in the table reflect the
dosage of both vasopressors. The number gives the highest dosage used on each day
cMissing data are caused by patients already being dead at this time point
CRP C-reactive protein, PCT procalcitonin PEEP positive end expiratory pressure, ROSC return of spontaneous circulation, WBC white blood cell count, PaO2/FiO2 Par-
tial pressure of oxygen in arterial blood [mmHg] / Fraction of inspired oxygen
For variables that are statistically different betwen patients with and without confirmed pneumonia given p-values are highlighted by bold characters.
Fig. 3 Influence of timing of antibiotic therapy on the length of the ICU stay and the length of hospital stay
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always be definite. This limitation may be even worse in
the setting of bedside radiography on the ICU. Therefore,
in our study, only patients with a chest X-ray scan catego-
rized “infiltrates definitely present” (as rated by an experi-
enced radiologist) could have confirmed pneumonia. This
may explain why only relatively few patients had con-
firmed pneumonia in our study, if compared with previous
reports where no information considering the reliability of
infiltrate detection on chest radiographies were given [8,
9, 13–18].
Impact of early pneumonia
In agreement with most previous reports [8, 9, 13], in
our study confirmed pneumonia and confirmed or prob-
able pneumonia were diagnosed as often in survivors as
in nonsurvivors. In contrast, MacLaren et al. [17] re-
ported higher incidences of pneumonia in OHCA pa-
tients with a good neurological recovery or Nielsen et al.
[14] reported higher incidences in patients alive at the
time of follow-up. However, these counterintuitive find-
ings likely relate to the fact that nonsurvivors may not
survive long enough to develop (and to have diagnosed)
pneumonia. Indeed, in our study, the median time to
death in nonsurvivors was only 5.5 (3.5–9.5) days. An-
other possible explanation for the absence of an impact
of early pneumonia on survival in our study may be the
probable adequacy of antibiotic therapy (nearly all pa-
tients received piperacillin–tazobactam).
Nonetheless, our data suggest prognostic relevance of
pneumonia, as indicated by a longer ICU and hospital stay
compared with patients without pneumonia. Moreover,
patients with confirmed pneumonia had a higher rate of
tracheotomy. Consistently, previous studies reported an
increased length of mechanical ventilation [9, 13], an in-
creased length of ICU stay [9, 13], and increased rate of
tracheotomy in patients with early pneumonia [13].
Predictors of pneumonia
Since diagnosis of pneumonia is difficult in the setting of
therapeutic hypothermia after OHCA and our data and
previous reports [9, 13] suggest a prognostic relevance
of early pneumonia, we tried to identify predictors of
pneumonia which could be assessed within the first
3 days after hospital admission. Out of 39 variables
(Table 2) compared between patients with and without
confirmed pneumonia, only the PEEP level on day 1 was
different between the two groups. The same was the case
for patients with confirmed or probable pneumonia if
compared with patients without pneumonia (Additional
file 3). Higher PEEP levels are usually applied if oxygen
diffusion is impaired and impaired oxygen diffusion is part
of the pathophysiology of pneumonia, which makes our
observation biologically plausible. Hence, higher PEEP
may well be indicative of early pneumonia, but may also
be a contributor to the pathogenesis because it leads to
bacterial translocation in an animal model [20]. With re-
spect to the retrospective design of our study, we therefore
cannot say whether higher PEEP levels are a cause or a
consequence of early pneumonia. This question remains
unanswered and requires further investigations (e.g., a
prospective randomized trial). However, in daily clinical
practice, an elevated PEEP on day 1 may be of limited use-
fulness regarding the prediction of pneumonia, since the
observed difference between PEEP values was only moder-
ate and with overlapping CIs.
Timing of antibiotic therapy
Since we failed to identify reliable early predictors of
pneumonia, we analyzed whether or not timing of anti-
biotic therapy is of prognostic relevance after OHCA.
Importantly, we observed no difference regarding the dur-
ation until an antibiotic therapy was initiated between sur-
vivors and nonsurvivors. In contrast, Davies et al. [21]
reported improved survival when antibiotics were given
within the first 7 days following OHCA. They therefore
conclude that early antibiotics improve survival after
OHCA. However, in their study the median delay between
ICU admission and first dose of antibiotics was 2.17 days.
Since, the mortality was highest in the early phase, some
patients may not have survived long enough to receive an-
tibiotics (rather than dying because they did not receive
antibiotics). Indeed, when the analysis was restricted to
patients surviving (at least) until day 3, no survival differ-
ence between patients with or without antibiotic therapy
was found [21]. In our study, all patients received antibi-
otics and antibiotic therapy was initiated after a median
time of 8.7 hours. Since, in this early phase, infection may
in most cases not be present, such an early start of antibi-
otics must be considered as prophylactic treatment. Re-
cently, a registry study reported a reduced incidence of
pneumonia in patients receiving antibiotic prophylaxis
after OHCA [15]. In contrast, we and others [9] found no
association between the timing of antibiotic treatment and
the incidence of pneumonia. In the report by Gagnon et
al. [15], antibiotic prophylaxis was given in 33.5 % of
patients. Interestingly, this percentage varied widely (0–
100 %) between different centers, demonstrating the ur-
gent need for more evidence for or against prophylactic
antibiotics after OHCA.
In our study, patients needing a tracheotomy during
their ICU stay had a later initiation of antibiotic ther-
apy. This finding may indicate a more disturbed re-
spiratory status and a more severe clinical course in
those patients. Accordingly, patients receiving antibi-
otics within 12 hours had a shorter ICU stay and
hospital stay compared with patients with a delayed
antibiotic therapy.
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Limitations
While our data may favor an early start of antibiotic
therapy in OHCA patients treated with hypothermia,
some potential limitations need to be mentioned. First,
our study was a single-center study performed on a med-
ical ICU. Thereby, we cannot assure that results are valid
for different sites (e.g., for surgical or neurological ICUs).
Second, our study focused on early pneumonia and we
did not collect data on pneumonia occurring after 7 days,
which is hospital acquired and may be predicted by differ-
ent factors (e.g., age and diabetes) [22]. Moreover, in the
literature, the definition of early pneumonia is not homo-
geneous: other reports used a 5-day cutoff value [8] to de-
fine early pneumonia, which would have resulted in a less
than 20 % lower number of patients with confirmed pneu-
monia in our study. Third, the present study had a retro-
spective design reporting empirical evidence in favor of an
early start of antibiotic therapy. However, because of the
retrospective design, causality between observed differ-
ences cannot be proven and confounding factors may be
present. On the other side, as a strength of our study, anti-
biotic therapy was very homogeneous (>95 % piperacillin
tazobactam) compared with previous reports where anti-
biotic therapy was either more heterogeneous [21] or not
reported [15]. Therefore, in our study, it is likely that dif-
ferences regarding the length of ICU and hospital stay are
caused by the timing of antibiotic therapy rather than by
the selected antibiotic. Furthermore, in contrast to a previ-
ous registry-based report [15], in our study ICU treatment
was strictly standardized and detailed information regard-
ing the reliability of infiltrate detection on chest radiogra-
phies, the definition of pneumonia, laboratory values, as
well as respiratory and hemodynamic parameters can be
provided.
Conclusion
Early pneumonia occurs frequently in patients treated
with therapeutic hypothermia after OHCA and may ex-
tend length of ICU stay, and length of hospital stay. Im-
portantly, diagnosis of pneumonia in the setting of
hypothermia after OHCA is challenging since common
criteria cannot be taken into consideration (e.g., fever), are
difficult to interpret (e.g., infiltrates on chest radiogra-
phies), or are available only with delay (microbiological
findings). Only a PEEP value on day 1 above 10.5 mbar
was found to be an early predictor of confirmed pneumo-
nia; other (more reliable) predictors could not be
identified. Since our data show that a delayed initiation of
antibiotic therapy after OHCA may increase the length of
ICU stay and hospital stay, prospective trials are
warranted to confirm these findings and to identify
the optimal point in time to initiate antibiotic
therapy.
Key messages
 Early pneumonia occurs frequently in patients
treated with therapeutic hypothermia after OHCA,
but is difficult to predict.
 Early pneumonia after OHCA may increase the rate
of tracheotomy and extend the length of the ICU
and hospital stay.
 A delayed initiation of antibiotic therapy after
OHCA may increase the length of the ICU and
hospital stay.
 Prospective trials are warranted to identify the
optimal point in time to initiate antibiotic therapy.
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